Miravant Medical Technologies Inc.
MRVT · OTC
12/31/2004 | 12/31/2003 | 12/31/2002 | 12/31/2001 | |
|---|---|---|---|---|
| Market Cap | $33,316 | $31,621 | $18,729 | $179,198 |
| - Cash | $3,112 | $1,030 | $723 | $1,458 |
| + Debt | $7,633 | $7,440 | $11,796 | $26,548 |
| Enterprise Value | $37,837 | $38,031 | $29,802 | $204,288 |
| Revenue | $0 | $0 | $499 | $4,683 |
| % Growth | – | -100% | -89.3% | – |
| Gross Profit | $0 | $0 | $20 | $3,749 |
| % Margin | – | – | 4% | 80.1% |
| EBITDA | -$12,601 | -$21,734 | -$13,553 | -$13,890 |
| % Margin | – | – | -2,716% | -296.6% |
| Net Income | -$15,896 | -$7,465 | -$15,960 | -$16,402 |
| % Margin | – | – | -3,198.4% | -350.2% |
| EPS Diluted | -0.48 | -0.3 | -0.78 | -0.88 |
| % Growth | -60% | 61.5% | 11.4% | – |
| Operating Cash Flow | -$11,528 | -$10,828 | -$8,570 | -$15,247 |
| Capital Expenditures | $0 | -$306 | $0 | -$287 |
| Free Cash Flow | -$11,528 | -$11,134 | -$8,570 | -$15,534 |